Nordicus Partners Corporation

NORD · OTC Markets OTCQB · Stock · Industrials

$3.94

+0.00% today

What Nordicus Partners does

Nordicus Partners Corporation, a biotech company specializing in developing breakthrough therapeutics for diseases with unmet medical needs in the United States. It develops medicines supporting oral health. The company was formerly known as EKIMAS Corporation and changed its name to Nordicus Partners Corporation in May 2023. Nordicus Partners Corporation was founded in 1993 and is based in Beverly Hills, California.

Key facts

Sector

Industrials

Industry

Consulting Services

Market cap

$75.5M

P/E (ttm)

—

Forward P/E

—

Dividend yield

—

Beta

-0.56

Profit margin

0.0%

Employees

—

Headquarters

Beverly Hills, CA, United States

Exchange

OTC Markets OTCQB

Website

nordicuspartners.com

Performance

1 Month

+45.9%

3 Months

+57.6%

6 Months

-2.5%

1 Year

-12.4%

5 Years

-73.7%

$1.4852-week range$5.95

Biggest setback — last 12 months

-60.8%

6 Oct 2025 → 22 Jun 2026

Fell from $5.20 to $2.04 — its sharpest sustained decline this year.

Biggest run-up — last 12 months

+101.0%

22 Jun 2026 → 17 Aug 2026

Ran from $2.04 to $4.10 — its strongest sustained advance this year.

Comparable companies

RILY

BRC Group Holdings, Inc.

$6.24 · -5.5%

SIEB

Siebert Financial Corp.

$2.52 · -6.7%

MDBH

MDB Capital Holdings, LLC

$2.57 · +0.8%

DOMH

Dominari Holdings Inc.

$2.23 · +2.3%

ATCH

AtlasClear Holdings, Inc.

$0.18 · +0.5%

Prices and company data are delayed reference figures from public sources and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.